Wang Yincang, Li Xiaodong, Lv Hang, Sun Lin, Liu Bo, Zhang Xiaofeng, Xu Xilin
Heilongjiang University of Chinese Medicine, Harbin, China.
The Third Department of Orthopedics and Traumatology, The Second Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, China.
Front Pharmacol. 2023 Mar 2;14:1128147. doi: 10.3389/fphar.2023.1128147. eCollection 2023.
Naringin is the main component of Drynaria. Modern pharmacological studies have shown that naringin has a wide range of pharmacological activities, including antioxidant, anti-inflammatory, anti-apoptotic, anti-ulcer, and anti-osteoporosis effects. Its therapeutic effects have been observed in various clinical models, such as atherosclerosis, cardiovascular diseases, diabetes, neurodegenerative diseases, and rheumatic diseases. This review investigates the pharmacological effects of naringin and the associated mechanisms in improving flap survival. This review will also provide a reference for future rational application of naringin, especially in research to improve flap survival.
柚皮苷是骨碎补的主要成分。现代药理学研究表明,柚皮苷具有广泛的药理活性,包括抗氧化、抗炎、抗凋亡、抗溃疡和抗骨质疏松作用。在各种临床模型中已观察到其治疗效果,如动脉粥样硬化、心血管疾病、糖尿病、神经退行性疾病和风湿性疾病。本综述探讨了柚皮苷在改善皮瓣存活方面的药理作用及相关机制。本综述还将为今后合理应用柚皮苷提供参考,尤其是在改善皮瓣存活的研究中。